Autoantibodies and Autoimmunity : Molecular Mechanisms in Health and Disease > Infectious Disease

본문 바로가기

회원메뉴

쇼핑몰 검색

회원로그인

오늘 본 상품

  • Autoantibodies and Autoimmunity : Molecular Mechanisms in Health and Disease
    Autoantibo
    370,000
  • HOME
Autoantibodies and Autoimmunity : Molecular Mechanisms in Health and Disease > Infectious Disease

Autoantibodies and Autoimmunity : Molecular Mechanisms in Health and Disease 요약정보 및 구매

상품 선택옵션 0 개, 추가옵션 0 개

  • 정가 : 406,000원 8%↓
  • 판매가 : 370,000원
  • 적립금 : 7,400원
  • 저자명 : Kenneth Michael Pollard
  • 출판사 : John Wiley & Sons
  • PAGE : 640
  • 배송비 : 주문시 결제
  • 발행일 : 2006-02-01
  • ISBN : 3527311416

선택된 옵션

  • 총 금액 :
    주문 수량
보관함 담기위시리스트

도서 소개

상품 상세설명

This is the first book to address all aspects of the biology of autoantibodies in a single volume, including a discussion of immunology, experimental models, clinical aspects, and the use of autoantibodies as probes in molecular and cellular biology.
The editor, currently professor at the W.M. Keck Autoimmune Disease Center of The Scripps Research Institute, has assembled an all-star team of authors to report on the latest research, technologies, and applications. Following an introductory chapter, the book goes on to cover such topics as cellular mechanisms of autoantibody production, clinical and diagnostic usefulness in human disease, and animal models used to study the elicitation of autoantibodies. The whole is rounded off with a look at future perspectives.
With its comprehensive coverage, this volume will appeal not only to immunologists and clinicians but also to cell and molecular biologists.

도서 목차

상품 상세설명

Part 1 Introductory Chapter.
1 Introduction (K. Michael Pollard).
1.1 Background.
1.2 Autoimmunity.
1.3 Autoantibodies as Diagnostic Markers.
1.4 Autoantibodies as Molecular and Cellular Probes.
1.5 Autoantibodies in Experimental Models of Autoimmunity.
1.6 Conclusions.
References.
2 Prefatory Chapter: The Importance of the Autoantibody-defined Epitope (Eng M. Tan).
2.1 Introduction.
2.2 The Uniqueness of the Autoantibody-defined Antigenic Determinant or the Autoepitope.
2.3 Conclusions.
References.
Part 2 Autoimmunity.
3 Self/Non-self Recognition (Alan G. Baxter).
3.1 Introduction.
3.2 Immunological Self.
3.3 The Clonal Selection Theory.
3.4 Self Post-Burnet.
3.5 Conclusions.
References.
4 Central and Peripheral Tolerance (Robert L. Rubin).
4.1 Introduction.
4.2 Ignorance of Lymphocytes to Target Antigen.
4.3 Central T-cell Tolerance.
4.4 Peripheral T-cell Tolerance.
4.5 B-cell Tolerance.
4.6 Breaking Tolerance.
4.7 Concluding Remarkss.
References.
5 T-B Cell Interactions in Autoimmunity (Barbara Schraml and Stanford L. Peng).
5.1 Introduction.
5.2 Direct T-B Cell Interactions: Receptor-mediated Contacts.
5.3 Indirect T-B Cell Interactions: Soluble Mediators.
5.4 The Nature of T-B Interactions in Autoimmunity: Ongoing Issues.
References.
6 Cell Death and Autoimmunity (Carlos A. Casiano and Fabio J. Pacheco).
6.1 Introduction.
6.2 Apoptosis.
6.3 Necrosis.
6.4 Impaired Lymphocyte Cell Death and Autoimmunity.
6.5 Cell Death–associated Autoantigen Proteolysis and Autoimmunity.
6.6 Defective Clearance of Apoptotic Cells and Autoimmunity.
6.7 Immunostimulatory Properties of Dying Cells.
6.8 Conclusions.
References.
7 Self-antigen Modification and Autoimmunity (Stuart M. Levine, Livia Casciola-Rosen, and Antony Rosen).
7.1 Introduction.
7.2 Learning to Ignore the “Self”: Immunologic Dominance and Crypticity.
7.3 Proteolytic Cleavage of Autoantigens During Apoptosis.
7.4 Cytotoxic Lymphocyte Granule–induced Death Pathways.
7.5 Many Autoantigens Are Specifically Cleaved by GrB, Generating Fragments Not Observed During Other Forms of Cell Death.
7.6 Grb-induced Cleavage of Tissue-specific Autoantigens.
7.7 Novel Conformation of Phenotype-specific Autoantigens.
7.8 Conclusion: A Model of Antigen Selection During Cell Death.
References.
Part 3 Autoantibodies as Diagnostic Markers.
8 Detection of Autoantibodies (Rufus W. Burlingame and Carol Peebles).
8.1 Comparison of Common Techniques.
8.2 Comparison of Common Tests.
8.3 Comparison of Antigens, Conjugates, and Cutoff Values.
8.4 Comparison of Multiplexed Assays.
References.
9 Synthetic Peptides for the Analysis of B-cell Epitopes in Autoantigens (Jean-Paul Briand and Sylviane Muller).
9.1 Introduction.
9.2 Autoantibodies as Diagnostic Markers.
9.3 Synthetic Peptides.
9.4 Peptide-based Methods for Detection and Quantification of Autoantibodies.
9.5 Multiple Peptide Presentation.
9.6 Peptides Containing Natural Modifications and Structural Motifs.
9.7 Peptides Containing Non-natural Modifications.
9.8 Mimotopes.
9.9 Cross-reactivity of Autoantibodies With Synthetic Peptides and the Cognate Protein.
9.10 Selected Examples of Epitope Mapping With Synthetic Peptides.
9.11 Concluding Remarks.
References.
10 Autoantibodies and Systemic Autoimmune Diseases (Karsten Conrad and Michael Bachmann).
10.1 Characteristics and Classification of Systemic Autoimmune Diseases.
10.2 Distinguishing Features of Systemic Autoimmune Disease-Specific Autoantibodies.
10.3 Autoantibodies as Diagnostic and/or Prognostic Markers in Systemic Autoimmune Diseases.
10.4 Summary and Perspectives.
References.
11 Autoantibodies in Systemic Lupus Erythematosus (Falk Hiepe).
11.1 Introduction and Historical Perspective.
11.2 Antinuclear Antibodies.
11.3 Antibodies to Cytoplasmic Antigens.
11.4 Antiphospholipid Antibodies.
11.5 Anti-C1q Antibodies.
11.6 Autoantibody Assessment in Clinical Routine.
References.
12 Autoantibodies in Rheumatoid Arthritis (Tsuneyo Mimori).
12.1 Introduction.
12.2 Anti-citrullinated Protein Antibodies.
12.3 Anti-Sa Antibodies.
12.4 Anti-RA33 Antibodies.
12.5 Anti-calpastatin Antibodies.
12.6 Anti-FRP Antibodies.
12.7 Anti-gp130-RAPS Antibodies.
12.8 Anti-GPI Antibodies.
12.9 Other RA-related Autoantibodies.
12.10 Conclusions.
References.
13 Autoantibodies and Organ-specific Autoimmunity (H. Bantel, J. Kneser, and M.P. Manns).
13.1 Role of Autoantibodies in Tissue-specific Organ Damage.
13.2 Autoantibodies and Autoantigens in Autoimmune Hepatitis.
13.3 Autoantibodies Frequently Associated with Autoimmune Hepatitis Type 1.
13.4 Autoantibodies and Autoantigens Associated with Autoimmune Hepatitis Type 2.
13.5 Autoantibodies and Autoantigens Associated with Autoimmune Hepatitis Type 3.
13.6 Autoantibodies Associated with Primary Biliary Cirrhosis.
13.7 Autoantibodies in Overlap Syndrome Between Autoimmune Hepatitis and Primary Biliary Cirrhosis.
13.8 Discussion and Conclusions.
References.
14 Autoantibodies in Autoimmune Thyroid Disease (Osvaldo Martinez and Bellur S. Prabhakar).
14.1 The Thyroid Gland.
14.2 Autoimmune Diseases of the Thyroid.
14.3 Autoantibodies in Thyroiditis.
14.4 TSHR-mediated Autoimmunity.
14.5 Development of Autoantibodies Against TSHR.
14.6 The Role of Genetic Factors.
14.7 The Role of Environmental Factors.
14.8 Assays for TSHR Autoantibodies.
14.9 Thyrotropin Receptor Down-modulation.
14.10 Functional Domains of TSHR.
14.11 TSAb Epitopes in GD.
14.12 TSBAbs with TBII Activity.
14.13 The Heterogeneous and Homogeneous TSAbs.
14.14 Immunomodulation.
14.15 Conclusions.
References.
15 Autoantibodies in Diabetes (Sarah M. Weenink and Michael R. Christie).
15.1 Introduction.
15.2 Islet-cell Antigens.
15.3 Islet Autoantibodies and the Prediction of Type 1 Diabetes.
15.4 Relationship of Islet Autoantibodies to T-cell Responses in Type 1 Diabetes.
15.5 Conclusions.
References.
Part 4 Autoantibodies as Molecular and Cellular Probes.
16 Autoantibody Recognition of Cellular and Subcellular Organelles (Ivan Raška and Šárka Růžičová).
16.1 Introduction.
16.2 Autoantibodies Are Important in Clinical and Basic Research.
16.3 Epitopes Recognized by Autoantibodies.
16.4 Immunocytochemistry and Autoantibodies.
16.5 Autoantibodies as Probes for Cytoplasmic Antigens.
16.6 Autoantibodies as Probes for Nuclear Antigens.
16.7 Conclusions.
References.
17 Autoantibody Recognition of Macromolecular Structures and Their Subunits (Erica A. Champion and Susan J. Baserga).
17.1 Autoantibodies Used to Probe the Function of Macromolecular Structures.
17.2 Autoantibodies as Probes for the Mechanism of Pre-mRNA Splicing.
17.3 U3 and the Box C/D Small Nucleolar RNAs (snoRNAs).
17.4 The La and Ro Autoantigens.
17.5 RNase P and RNase MRP.
17.6 The Exosome.
17.7 NOR-90/hUBF and RNA Polymerases I, II, and III.
References.
18 Autoantibodies and the Cloning and Characterization of Cellular Constituents (Edward K. L. Chan).
18.1 Introduction.
18.2 cDNA Expression Cloning as a Tool to Identify Autoantigens.
18.3 Autoantibodies to IGF-II mRNA-binding Protein p62 and Overexpression of p62 in Human Hepatocellular Carcinoma.
18.4 Unique Features of Golgi Complex Autoantigens.
18.5 Cloning of GW182 Autoantigen and Identification of GW Bodies.
18.6 Future Perspectives.
References.
19 Tolerance and Immunity to the Ro/La RNP Complex (Catherine L. Keech, Tom P. Gordon, and James McCluskey).
19.1 Introduction.
19.2 The Nature of the Autoimmune Response to La.
19.3 The Ro/La Ribonucleoprotein Complex.
19.4 Autoimmune Findings in Humans.
19.5 Autoimmunity to La in Experimental Models.
19.6 Tolerance to Nuclear Antigens.
19.7 Lack of Tolerance in the B-cell Compartment.
19.8 Tolerance in the T-cell Compartment.
19.9 Induction of Disease.
19.10 Anti-La Autoantibodies Are Pathogenic in the Neonatal Lupus Syndrome.
19.11 Concluding Remarks.
References.
20 Autoantibody Recognition of Functional Sites (Carlo Selmi, Sabine Oertelt, Pietro Invernizzi, Mauro Podda, and M. Eric Gershwin).
20.1 Introduction.
20.2 Anti-mitochondrial Antibodies in Primary Biliary Cirrhosis.
20.3 Enzyme Inhibition.
20.4 Xenobiotics and AMA.
20.5 Microorganisms and AMAs.
20.6 AMAs in the Pathogenesis of PBC.
20.7 Other Autoantibodies in PBC.
20.8 Concluding Remarks and Future Directions.
References.
Part 5 Autoantibodies in Experimental Models of Autoimmunity.
21 Novel Mechanisms of Autoantibody Induction and Pathogenesis in Experimental Autoimmunity (Yulius Y. Setiady and Kenneth S.K. Tung).
21.1 Introduction.
21.2 The Autoimmune Ovarian Disease (AOD) Models.
21.3 Mechanism of Induction and Antigen Specificity of Autoantibodies.
21.4 Pathogenic Mechanisms of Autoantibodies in Autoimmune Disease.
References.
22 Environmental Factors That Contribute to Autoimmunity (Per Hultman).
22.1 Relation Between Genetic and Environmental Factors in Autoimmunity.
22.2 Environmental Factors in Autoimmunity.
22.3 Xenobiotics.
22.4 Microbial Agents in Autoimmunity.
22.5 Hormones in Autoimmunity.
22.6 Prenatal Exposure and Postnatal Autoimmune Effects.
22.7 Acceleration and Aggravation of Autoimmunity by Environmental Agents.
22.8 Comments on the Accelerating Effect of Metals on Autoimmunity.
22.9 Concluding Remarks.
References.
23 Genetics of Autoantibody Production in Mouse Models of Lupus (Dwight H. Kono and Argyrios N. Theofilopoulos).
23.1 Introduction.
23.2 Identifying Genes Predisposing to Systemic Autoimmunity.
23.3 Mouse Models of SLE in Mapping Studies.
23.4 Lupus Quantitative Trait Loci.
23.5 Loci in NZB, NZW, and NZBNZW Recombinant Inbred Mice.
23.6 Loci Identified in Crosses of MRL-FaslprMice.
23.7 Loci in BXSB Crosses.
23.8 Loci in Other Spontaneous Lupus Crosses.
23.9 Loci Identified in Induced or Mutant Models of Lupus.
23.10 Conclusions.
References.
24 Genetic Manipulation (Matthew C. Pickering and Marina Botto).
24.1 Introduction.
24.2 Genetic Pathways Leading to Autoimmunity: Lessons from Genetically Manipulated Models.
24.3 Epistatic Effects of Background Genes on Gene-targeted Models of SLE: The Importance of Appropriate Controls.
24.4 Conclusions.
References.
25 Perspectives (K. Michael Pollard).
25.1 Introduction.
25.2 Autoantibodies and Autoimmunity.
25.3 Autoantibodies as Diagnostic Markers.
25.4 Autoantibodies as Molecular and Cellular Probes.
25.5 Autoantibodies in Experimental Models of Autoimmunity.
References.
Subject Index.

도서문의

등록된 상품문의

상품문의가 없습니다.

관련도서

등록된 상품이 없습니다.

배송정보

25479cd413c61311918c7e43d7a20bbd_1564381803_05.jpg


주문하신 책과 다른 책이 잘못 배송되었거나 배송된 도서가 파본인 경우, 도서를 아래의 두가지 방법 중 하나를 선택하여 반송해 주시면 됩니다.

택배 또는 우편등기를 통한 반송 오발송이나 파본된 책에 대한 내용을 고객센터(033-745-8879)나 반품 및 교환 문의를 통해 알려 주시고,

오발송/파본 도서를 보내주시면 확인 후 택배 또는 우편으로 원래 주문하신 정상적인 책을 보내드립니다.


* 반송할 주소 : 강원도 원주시 판부면 매봉길 30-14  1층  의방서원


반송하실 때, 파본 도서의 경우 인쇄되지 않은 페이지나, 중복된 페이지, 찢어진 부분 등 구체적인 파본 부분을 포스트잇이나 메모지에 적어 표시해 주시면 감사하겠습니다.

또한 주문번호를 같이 기재해 주시면 주문자 확인 등에 소요되는 시간을 단축할 수 있어 환불이나 교환 등의 사후처리를 보다 빨리 할 수 있습니다.

물론, 반송비용과 재발송 비용은 본사에서 부담합니다. 

책을 보내실 때 주문번호와 함께 환불해 드릴 계좌번호를 써서 보내주십시오.





25479cd413c61311918c7e43d7a20bbd_1564381803_12.jpg


의방서원 회원 약관 및 소비자 보호원 및 공정거래위원회 규정 표준 약관에 근거해 환불이 가능합니다. 

하지만 다른 상품과 달리 도서는 상품 외형의 가치보다는 그 속에 담겨 있는 내용에 가치가 있는 것이기 때문에 반품가능 기간이 정해져 있습니다.

반품을 원하시는 도서는 받으신지 5일 이내에 등기우편을 통해 저희 회사로 보내주십시오.

단, 오발송이나 파본된 도서가 아닌 경우에는 배송 비용은 회원님께서 부담하셔야 합니다. 환불시 배송비용을 제외하고 난 후 송금해 드립니다.

이렇게 보내주신 책은 저희 반송 담당자의 확인을 거친 후 환불 처리되게 됩니다. 구체적인 반품 과정은 아래와 같습니다.


1. 전화 033-745-8879 연락 후 

   반품/교환 문의를 통해 반품하실 도서명을 저희에게 알려 주신 후 등기우편으로 보내주시면 됩니다.

2. 반품하실 주소는 위의 반송 주소와 동일합니다.

3. 보내실 때 반품 도서의 주문번호와 환불해 드릴 계좌번호를 메모지에 적어 함께 넣어주시기 바랍니다.

   이러한 메모가 있는 경우에 보다 신속하게 반품 처리가 될 수 있습니다.


공지사항

더보기

단체ㆍ대량구매 할인

yb8879@hanmail.net으로 신청!
담당자 : 010-7361-8879로 전화주시면
친절한 안내를 드리겠습니다.

무통장 입금계좌

KB국민은행 303-01-0446-599 국민은행 303-01-0446-599
예금주 : 임동원

고객센터

더보기
고객센터
  • 원주 본점033-745-8879
  • 원주 연세대점033-746-7370
  • 제천 세명대점043-648-8997
  • 한의학담당033-745-8879
  • 간호학담당033-746-7370
  • 의학담당033-746-7370
  • 치의학담당033-746-7370
  • 약학담당033-746-7370
의방서원 우편번호 26399 강원도 원주시 판부면 매봉길 30-14 1층 대표 : 임동원
본점 033-745-8879 원주 연세대점 033-746-7370 제천 세명대점 043-648-8997 E-mail : yb8875@naver.com
사업자 등록번호 : 224-06-51432 [사업자정보확인] 통신판매업신고번호 : 제2005-126호 개인정보관리책임자 : 인터넷팀
COPYRIGHT (C) YIBANG MEDICALBOOK CENTER 1999-2020. ALL RIGHTS RESERVED.
공정거래위원회 NICE페이먼츠